JPWO2020260947A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020260947A5
JPWO2020260947A5 JP2021576862A JP2021576862A JPWO2020260947A5 JP WO2020260947 A5 JPWO2020260947 A5 JP WO2020260947A5 JP 2021576862 A JP2021576862 A JP 2021576862A JP 2021576862 A JP2021576862 A JP 2021576862A JP WO2020260947 A5 JPWO2020260947 A5 JP WO2020260947A5
Authority
JP
Japan
Prior art keywords
vegf
polypeptide sequence
vegfr
chimeric
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021576862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539067A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/000538 external-priority patent/WO2020260947A1/en
Publication of JP2022539067A publication Critical patent/JP2022539067A/ja
Publication of JPWO2020260947A5 publication Critical patent/JPWO2020260947A5/ja
Pending legal-status Critical Current

Links

JP2021576862A 2019-06-25 2020-06-24 安定化キメラ合成タンパク質及びその治療的使用 Pending JP2022539067A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962866190P 2019-06-25 2019-06-25
US62/866,190 2019-06-25
PCT/IB2020/000538 WO2020260947A1 (en) 2019-06-25 2020-06-24 Stabilized chimeric synthetic proteins and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
JP2022539067A JP2022539067A (ja) 2022-09-07
JPWO2020260947A5 true JPWO2020260947A5 (ru) 2023-07-04

Family

ID=72086914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021576862A Pending JP2022539067A (ja) 2019-06-25 2020-06-24 安定化キメラ合成タンパク質及びその治療的使用

Country Status (11)

Country Link
US (1) US20220305105A1 (ru)
EP (1) EP3990010A1 (ru)
JP (1) JP2022539067A (ru)
KR (1) KR20220058527A (ru)
CN (1) CN114269792A (ru)
AU (1) AU2020301638A1 (ru)
BR (1) BR112021026132A2 (ru)
CA (1) CA3144845A1 (ru)
IL (1) IL289203A (ru)
MX (1) MX2021015922A (ru)
WO (1) WO2020260947A1 (ru)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238190A (en) 1963-10-23 1966-03-01 Madaus & Co K G Fa Dr Aescin recovery
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
UA56132C2 (ru) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиция вакцины (варианты), способ стабилизации qs21 по отношению к гидролизу (варианты), способ приготовления вакцины
JPH10147952A (ja) 1996-11-18 1998-06-02 Komatsu Ltd ブルドーザのドージング装置
US6645495B1 (en) 1997-08-29 2003-11-11 Antigenics, Inc. Compositions of saponin adjuvants and excipients
WO2000062800A2 (en) 1999-04-19 2000-10-26 Smithkline Beecham Biologicals Sa Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
CU22999A1 (es) 2001-12-04 2004-10-12 Centro Inmunologia Molecular Método de tratamiento de enfermedades malignas e infecciosas crónicas
CN108864291A (zh) * 2011-11-23 2018-11-23 拜奥文斯瑞有限公司 重组蛋白及其治疗用途
JP6873530B2 (ja) * 2013-03-15 2021-05-19 イン3バイオ・リミテッドIn3Bio Ltd. 自己組織化合成タンパク質(Self−Assembling Synthetic Proteins)
EP3244908A4 (en) * 2015-01-16 2018-09-12 The Board of Trustees of The Leland Stanford Junior University Vegf variant polypeptide compositions
IL300235A (en) * 2017-07-18 2023-03-01 In3Bio Ltd Synthetic proteins and their therapeutic uses

Similar Documents

Publication Publication Date Title
JP7323949B2 (ja) フラジェリン融合タンパク質及びその使用
US10570193B2 (en) Binding moieties for biofilm remediation
RU2010110812A (ru) Композиции гуманизированных слитых белков notch и способы лечения
JP4741800B2 (ja) 抗血管新生活性療法
JP2017101068A5 (ru)
JP2009520758A5 (ru)
US20150299298A1 (en) Binding moieties for biofilm remediation
JP2018104461A5 (ru)
JP2012531219A5 (ru)
PH12020551648A1 (en) Human neuregulin-1 (nrg-1) recombinant fusion protein compositions and methods of use thereof
WO2017192594A1 (en) Binding moieties for biofilm remediation
WO2016154491A1 (en) Binding moieties for biofilm remediation
JP2012517425A5 (ru)
JP6032735B2 (ja) Vegf結合性融合ペプチド
RU2020106669A (ru) Синтетические белки и пути их терапевтического применения
JP2020527579A5 (ru)
JPWO2020260947A5 (ru)
RU2022101529A (ru) Стабилизированные химерные синтетические белки и пути их терапевтического применения
WO2019228032A1 (zh) 磷酸化多肽抗原疫苗及其制备方法和应用
JPH11506337A (ja) 骨刺激因子
RU2020115161A (ru) Днк моноклональных антител против ctla-4 для лечения и профилактики рака
HRP20221314T1 (hr) Molekularno porijeklo alergije
CN101341170A (zh) 抗白介素-22结合蛋白的抗体及其用途
CA2563332A1 (en) Therapeutic uspa1-derived peptides
JP2017043625A (ja) Vegf結合性ペプチド